Core Research Applications Metabolic health : Preclinical data indicate that NNMT inhibition may reduce fat cell size and support improved insulin sensitivity and glucose tolerance in diet-induced obesity models
Frequently Asked Questions What is the difference between GHK-CU and Copper Tripeptide-1
Without a substantial change in UK medicines law or the development of a fully proven and licensed non-injectable alternative for malabsorption conditions like PA, the injection will remain a Prescription-Only Medicine
Oral Supplements: The Traditional Approach Oral B12 supplements have served as the conventional supplementation method for decades, offering accessibility and variety in forms and dosages
In 2017, Neelakantan and colleagues first systematically characterized 5amino1mq during screening for selective NNMT inhibitors, with findings published in Biochemical Pharmacology - marking the official discovery and public reporting of the compound.Through structural modification of quinolinebased precursors, the team identified 5amino1mq as a small, membranepermeable molecule with the chemical formula CHN.With an extremely low IC value, it became one of the most promising selective NNMT inhibitors available at the time, with high specificity and no significant inhibition of other metabolically relevant enzymes